| Literature DB >> 23889909 |
Gretchen M Ehrenkaufer, Gareth D Weedall, Daryl Williams, Hernan A Lorenzi, Elisabet Caler, Neil Hall, Upinder Singh.
Abstract
BACKGROUND: Several eukaryotic parasites form cysts that transmit infection. The process is found in diverse organisms such as Toxoplasma, Giardia, and nematodes. In Entamoeba histolytica this process cannot be induced in vitro, making it difficult to study. In Entamoeba invadens, stage conversion can be induced, but its utility as a model system to study developmental biology has been limited by a lack of genomic resources. We carried out genome and transcriptome sequencing of E. invadens to identify molecular processes involved in stage conversion.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23889909 PMCID: PMC4053983 DOI: 10.1186/gb-2013-14-7-r77
Source DB: PubMed Journal: Genome Biol ISSN: 1474-7596 Impact factor: 13.583
Figure 1Comparisons of protein length, intergenic region length, exon number and gene family size in the . In all plots, the black line represents E. invadens and the red line represents E. histolytica. (a) Distribution of protein lengths for the translated coding sequences. (b) Distribution of intergenic sequence lengths. For display purposes, the x-axis is plotted in a log scale. (c) Distribution of the number of exons per gene. (d) Distribution of the number of putative paralogous genes belonging to multi-gene families. Gene families were defined based on shared functional domains (see Materials and methods for detailed description).
Introns detected by whole transcriptome mapping
| Sample | Introns | Confirm annotation (%)a | Match 5' | Match 3' | Novel |
|---|---|---|---|---|---|
| Trophozoite | 1,628 | 1,345 (23%) | 19 | 11 | 253 |
| Cyst_8h | 2,163 | 1,771 (30%) | 23 | 10 | 359 |
| Cyst_24h | 1,955 | 1,536 (26%) | 21 | 12 | 386 |
| Cyst_48h | 1,047 | 811 (14%) | 15 | 5 | 216 |
| Cyst_72h | 1,272 | 1,027 (17%) | 9 | 6 | 230 |
| Excyst_2h | 1,438 | 1,229 (21%) | 12 | 6 | 191 |
| Excyst_8h | 764 | 666 (11%) | 5 | 2 | 91 |
| All | 3,239 | 2,470 (42%) | 35 | 17 | 717 |
Percentage of 5,894 introns predicted from genome annotation.
Figure 2Changes in cell morphology during encystation and excystation. Cell morphology at different time points during encystation and excystation. The top row shows representative phase contrast images; the bottom row shows cells stained with Syto-11 to stain the nuclei. Note that the numbers of nuclei vary between one and four per cell, indicating some heterogeneity among cells in the timing of events during encystation, with the majority of mature cysts with four nuclei. Scale bar indicates 10 µm. Total library size and Pearson correlation between biological replicates is shown for each time point.
Figure 3Analysis of . (a) Sequence logos representing consensus sequences at 5' and 3' intron-exon junctions for introns detected by whole transcriptome mapping (upper) and for introns predicted by computational gene prediction but not confirmed by transcriptome mapping (lower). The start and end of the intron are indicated by the thick black line and intronic sequence by the thin line. The dashed line indicates that the central portions of the introns were not analyzed. (b) Example of a probably incorrect gene model (EIN_014820, thick black line) that contains an intron (thin black line) that is contradicted by transcriptome mapping (depth of coverage shown in grey plot). (c) Example of probably incorrect gene model (EIN_035150, part shown with predicted translation) in which the predicted intron (dashed line) is supported by whole transcriptome mapping at the 5' junction only. The correct intron is indicated by the solid black line. The corrected protein is shorter by four amino acids (TDET).
Figure 4Temporal gene expression profiles. Temporal gene expression profiles containing significantly more genes than expected by chance. (a) Expression profiles during encystation. (b) Expression profiles during excystation. Each box shows a representative expression profile (black line) and profiles of genes assigned to the profile (red lines). The profile ID number is shown in each box. Clusters of related profiles have the same color. The numbers of genes assigned to a profile/cluster are shown to the right. All profiles are shown in Additional file 8 and data for all genes are tabulated in Additional file 4.
Gene Ontology terms associated with temporal gene expression profiles during encystation
| Profile/clustera | GO category name | Fold enrichmentb | Corrected |
|---|---|---|---|
| Profile 16 | Translation | 7.8 | <0.001 |
| Structural constituent of ribosome | 7.9 | <0.001 | |
| Ribosome | 8.1 | <0.001 | |
| Protein binding | 2.9 | <0.001 | |
| Actin binding | 4.9 | <0.001 | |
| Glycolysis | 12.2 | <0.001 | |
| Intracellular | 1.7 | <0.001 | |
| Cytoplasm | 4 | 0.002 | |
| Catalytic activity | 2.3 | 0.002 | |
| Oxidoreductase activity | 3.4 | 0.002 | |
| Oxidation-reduction process | 4 | 0.038 | |
| Profile 15 | Translation | 12.1 | <0.001 |
| Structural constituent of ribosome | 11.8 | <0.001 | |
| Ribosome | 11 | <0.001 | |
| Small ribosomal subunit | 24.3 | <0.001 | |
| Intracellular | 2.2 | <0.001 | |
| Aminoacyl-tRNA ligase activity | 16.6 | <0.001 | |
| tRNA aminoacylation for protein translation | 16.6 | <0.001 | |
| Cytoplasm | 6.5 | <0.001 | |
| NAD binding | 16.5 | <0.001 | |
| Metabolic process | 3 | 0.018 | |
| Cluster (profiles 24, 41) | Heat shock protein binding | 6.7 | 0.004 |
| Profile 24 | Heat shock protein binding | 8.5 | 0.006 |
| Unfolded protein binding | 6.3 | 0.01 | |
| Protein folding | 5.7 | 0.014 | |
| Cluster (profiles 31, 34) | Metabolic process | 3.4 | <0.001 |
| Catalytic activity | 2.5 | <0.001 | |
| Binding | 2.3 | <0.001 | |
| Phosphatidylcholine-sterol O-acyltransferase activity | 9 | 0.016 | |
| Membrane coat | 5.8 | 0.016 | |
| Structural molecule activity | 6.8 | 0.018 | |
| Vesicle-mediated transport | 3.3 | 0.04 | |
| Profile 31 | Metabolic process | 3.5 | <0.001 |
| Catalytic activity | 2.6 | <0.001 | |
| Binding | 2.4 | <0.001 | |
| Membrane coat | 6.8 | 0.002 | |
| Phosphatidylcholine-sterol O-acyltransferase activity | 10.5 | 0.002 | |
| Structural molecule activity | 7.9 | 0.002 | |
| Vesicle-mediated transport | 3.9 | 0.004 | |
| Lipid metabolic process | 4.9 | 0.034 | |
| Profile 19 | Vesicle-mediated transport | 5.1 | 0.062 |
| Nucleic acid binding | 2.2 | 0.464 | |
| Profile 21 | Integral to membrane | 4.7 | 0.014 |
| Membrane | 4.1 | 0.038 | |
| Profile 20 | Hydrolase activity | 4 | 0.014 |
| Cluster (profiles 32 13) | Methionine adenosyltransferase activity | 30.5 | <0.001 |
| One carbon metabolic process | 30.5 | <0.001 | |
| DNA binding | 3.6 | <0.001 | |
| Nucleosome | 12.2 | 0.002 | |
| Nucleus | 3 | 0.002 | |
| Nucleosome assembly | 8 | 0.002 | |
| Sequence-specific DNA binding | 6.9 | 0.034 | |
| Profile 32 | Methionine adenosyltransferase activity | 48.7 | <0.001 |
| One carbon metabolic process | 48.7 | <0.001 | |
| DNA binding | 3.8 | <0.001 | |
| Nucleus | 3.3 | 0.01 | |
| Profile 13 | Intracellular protein transport | 5.3 | 0.002 |
| Intracellular | 2.3 | 0.002 | |
| GTP binding | 3.3 | 0.002 | |
| Small GTPase mediated signal transduction | 3.1 | 0.002 | |
| Protein transport | 3.4 | 0.004 | |
| Nucleocytoplasmic transport | 5.6 | 0.016 | |
| GTPase activity | 4.3 | 0.036 |
aSee Figure 4 and Additional file 8 for profiles/clusters. bRatio of the observed number of genes with associated GO term to the number expected for a profile of the same size. cP-value Bonferroni-corrected for multiple tests.
Gene Ontology terms associated with temporal gene expression profiles during excystation
| Profile/clustera | GO category name | Fold enrichmentb | Corrected |
|---|---|---|---|
| Profile 45 | Protein binding | 3.1 | 0.002 |
| Catalytic activity | 3.4 | 0.002 | |
| Metabolic process | 3.4 | 0.05 | |
| Cluster (profiles 49, 40, 41, 37, 48, 44) | Zinc ion binding | 1.7 | <0.001 |
| Catalytic activity | 1.7 | <0.001 | |
| Pyridoxal phosphate binding | 3.7 | 0.024 | |
| Nucleic acid binding | 1.6 | 0.028 | |
| Heat shock protein binding | 3 | 0.032 | |
| Profile 49 | Helicase activity | 4.3 | 0.042 |
| Ubiquitin-dependent protein catabolic process | 4.1 | 0.05 | |
| Profile 40 | Binding | 2.1 | 0.01 |
| Zinc ion binding | 2 | 0.038 | |
| Profile 41 | Membrane | 3.7 | 0.006 |
| Profile 37 | Protein binding | 2.4 | 0.022 |
| Catalytic activity | 2.5 | 0.048 | |
| Profile 47 | Oxidoreductase activity | 6.3 | 0.018 |
| Cluster (profiles 0, 4, 7, 8, 11, 15, 16, 17, 18) | Ribosome | 3.7 | <0.001 |
| Structural constituent of ribosome | 3.6 | <0.001 | |
| Translation | 3.1 | <0.001 | |
| Intracellular | 1.5 | <0.001 | |
| DNA binding | 2.1 | <0.001 | |
| Nucleosome | 5.6 | <0.001 | |
| Nucleus | 2.1 | <0.001 | |
| Nucleosome assembly | 4 | 0.002 | |
| Signal transduction | 1.6 | 0.024 | |
| Threonine-type endopeptidase activity | 4.2 | 0.044 | |
| Proteasome core complex | 4.2 | 0.044 | |
| Proteolysis involved in cellular protein catabolic process | 4.2 | 0.044 | |
| Profile 17 | Ribosome | 7.1 | <0.001 |
| Structural constituent of ribosome | 6.8 | <0.001 | |
| Translation | 6.3 | <0.001 | |
| Intracellular | 1.9 | 0.002 | |
| Profile 18 | Intracellular | 2.1 | 0.006 |
| Ribosome | 5 | 0.006 | |
| Structural constituent of ribosome | 4.8 | 0.008 | |
| Translation | 4.2 | 0.02 | |
| Signal transduction | 3 | 0.024 | |
| Profile 7 | Ribosome | 5.3 | 0.002 |
| Structural constituent of ribosome | 5.1 | 0.002 | |
| Translation | 4 | 0.012 | |
| DNA binding | 3.1 | 0.04 | |
| Profile 8 | Intracellular | 2.3 | 0.01 |
| Protein transport | 3.6 | 0.012 | |
| GTP binding | 3 | 0.024 | |
| Catalytic activity | 3.2 | 0.024 | |
| Small GTPase mediated signal transduction | 2.9 | 0.032 | |
| Profile 16 | DNA binding | 4.4 | <0.001 |
aSee Figure 4 and Additional file 8 for profiles/clusters. bRatio of the observed number of genes with associated GO term to the number expected for a profile of the same size. cP-value Bonferroni-corrected for multiple tests.
Figure 5Genes up-regulated and down-regulated in pairwise comparisons. (a) Total number of genes significantly up- or down-regulated (as determined by Cuffdiff) in 8 h, 24 h, 48 h and 72 h encystation compared to trophozoites, and 2 h and 8 h excystation, compared to 72 h cysts, is shown. (b) Venn diagram showing overlap between the sets of genes up- or down-regulated in 72 h cysts compared to trophozoites, and genes up- or down-regulated in 8 h excysting parasites compared to 72 h cysts.
Figure 6Confirmation of transcript expression levels by Northern blot analysis. Northern blot analysis of samples from trophozoites, at 24 and 72 h post-encystation, and at 8 h post-excystation. Total RNA (20 µg) from each time point was used and expression levels of genes with regulated expression determined. For each probe, the gene being probed and its annotation are listed. A gene with no significant changes in gene expression (EIN_192230) was used as a loading control. The expression level (FPKM) at each time point included in the blot is shown for each gene.
Figure 7Changes in the estimated expression levels of known encystation associated genes. Expression levels (FPKM) are plotted for each time point during encystation and excystation. Data for all time points used in this study (trophozoite, 8 h, 24 h, 48 h, and 72 h encystation and 2 h and 8 h excystation) are shown. Dotted line indicates transition between encystation and excystation. (a) Expression of genes encoding chitin synthase domain-containing proteins. (b) Expression of genes encoding chitin binding lectins. (c) Expression of genes encoding chitinase domain-containing proteins
Pfam domains enriched in up- and down-regulated genes
| Pfam domain IDa | Pfam domain description | Domains in genomeb | Domains in subsetc | |
|---|---|---|---|---|
| PF00962 | Adenosine/AMP deaminase | 10 | 4 | 1.00 × 10-4 |
| PF01370 | NAD dependent epimerase/dehydratase family | 7 | 3 | 6.45 × 10-4 |
| PF01380 | Sugar isomerase domain | 3 | 2 | 2.20 × 10-3 |
| PF01416 | tRNA pseudouridine synthase | 5 | 2 | 6.92 × 10-3 |
| PF06978 | Ribonucleases P/MRP protein subunit POP1 | 2 | 2 | 7.52 × 10-4 |
| PF02463 | Structural maintenance of chromosomes superfamily | 9 | 3 | 1.46 × 10-3 |
| PF08221 | RNA polymerase III subunit RPC82 helix-turn-helix domain | 3 | 2 | 2.20 × 10-3 |
| PF00620 | RhoGAP domain | 97 | 10 | 2.61 × 10-4 |
| PF00566 | Rab-GTPase-TBC domain | 62 | 6 | 5.48 × 10-3 |
| PF08743 | DNA repair | 3 | 2 | 2.20 × 10-3 |
| PF03114 | Protein dimerisation domain | 12 | 3 | 3.53 × 10-3 |
| PF09777 | Osteopetrosis-associated transmembrane protein 1 precursor | 2 | 2 | 7.52 × 10-4 |
| PF00888 | Cullin family ubiquitin ligase scaffold protein | 11 | 3 | 2.72 × 10-3 |
| PF10557 | Cullin protein neddylation domain | 12 | 3 | 3.53 × 10-3 |
| PF00643 | B-box zinc finger | 15 | 3 | 6.72 × 10-3 |
| PF00578 | Alkyl hydroperoxide reductase and thiol specific antioxidant | 17 | 3 | 9.50 × 10-3 |
| PF12796 | Ankyrin repeats | 87 | 9 | 5.03 × 10-4 |
| PF03197 | Bacteriophage FRD2 protein | 3 | 2 | 2.20 × 10-3 |
| PF07534 | unknown function | 210 | 19 | 4.34 × 10-6 |
| PF06045 | Rhamnogalacturonate lyase family | 6 | 5 | 2.74 × 10-6 |
| PF00704 | Glycosyl hydrolases family 18 | 7 | 5 | 9.07 × 10-6 |
| PF07651 | Phosphatidylinositol 4,5-bisphosphate binding | 8 | 4 | 4.96 × 10-4 |
| PF07653 | Variant SH3 domain | 21 | 6 | 6.16 × 10-4 |
| PF00018 | SH3 domain: protein-protein interaction | 32 | 7 | 1.19 × 10-3 |
| PF00614 | Phospholipase D active site motif | 2 | 2 | 2.98 × 10-3 |
| PF00069 | Protein kinase domain | 510 | 41 | 3.42 × 10-3 |
| PF00806 | Pumilio-family RNA binding repeat | 60 | 12 | 6.48 × 10-5 |
| PF06978 | Ribonucleases P/MRP protein subunit POP1 | 2 | 2 | 2.98 × 10-3 |
| PF00352 | Transcription factor TFIID (or TATA-binding protein, TBP) | 11 | 4 | 1.98 × 10-3 |
| PF00620 | RhoGAP domain | 97 | 18 | 3.50 × 10-6 |
| PF00225 | Kinesin motor domain | 6 | 3 | 2.75 × 10-3 |
| PF03953 | Tubulin C-terminal domain | 6 | 3 | 2.75 × 10-3 |
| PF00443 | Ubiquitin carboxyl-terminal hydrolase | 29 | 6 | 3.45 × 10-3 |
| PF13476 | ATPase domain | 10 | 4 | 1.33 × 10-3 |
| PF04506 | Integral membrane protein, possible sugar transporter | 2 | 2 | 2.98 × 10-3 |
| PF12796 | Ankyrin repeats | 87 | 13 | 6.03 × 10-4 |
| PF07534 | Unknown function | 210 | 31 | 3.07 × 10-7 |
| PF00128 | Alpha amylase, catalytic domain | 24 | 7 | 5.95 × 10-5 |
| PF02784 | Pyridoxal-dependent decarboxylase, pyridoxal binding domain | 5 | 3 | 8.37 × 10-4 |
| PF12697 | Alpha/beta hydrolase family | 8 | 3 | 4.08 × 10-3 |
| PF00614 | Phospholipase D active site motif | 2 | 2 | 2.04 × 10-3 |
| PF00806 | Pumilio-family RNA binding repeat | 60 | 12 | 1.05 × 10-5 |
| PF00773 | Catalytic domain of ribonuclease II | 10 | 4 | 6.58 × 10-4 |
| PF01885 | RNA 2'-phosphotransferase, Tpt1/KptA family | 3 | 2 | 5.83 × 10-3 |
| PF06978 | Ribonucleases P/MRP protein subunit POP1 | 2 | 2 | 2.04 × 10-3 |
| PF04054 | CCR4-Not complex component - global regulator of transcription | 5 | 3 | 8.37 × 10-4 |
| PF00145 | C-5 cytosine-specific DNA methylase | 2 | 2 | 2.04 × 10-3 |
| PF08221 | RNA polymerase III subunit RPC82 helix-turn-helix domain | 3 | 2 | 5.83 × 10-3 |
| PF08743 | DNA repair | 3 | 2 | 5.83 × 10-3 |
| PF02144 | Repair protein Rad1/Rec1/Rad17 | 3 | 2 | 5.83 × 10-3 |
| PF02145 | Rap/ran-GAP | 33 | 6 | 2.67 × 10-3 |
| PF00620 | RhoGAP domain | 97 | 11 | 2.92 × 10-3 |
| PF04506 | Integral membrane protein, possible sugar transporter | 2 | 2 | 2.04 × 10-3 |
| PF01436 | NHL repeat | 8 | 3 | 4.08 × 10-3 |
| PF05237 | MoeZ/MoeB domain: unknown function | 3 | 2 | 5.83 × 10-3 |
| PF07534 | Unknown function | 210 | 20 | 8.17 × 10-4 |
| PF00723 | Glycosyl hydrolases family 15 | 6 | 4 | 4.71 × 10-4 |
| PF00534 | Glycosyl transferases group 1 | 4 | 3 | 1.75 × 10-3 |
| PF01592 | Iron-sulfur cluster assembly | 148 | 24 | 2.86 × 10-4 |
| PF00076 | RNA recognition motif (aka RRM, RBD, or RNP domain) | 36 | 9 | 1.11 × 10-3 |
| PF00270 | DEAD/DEAH box helicase | 12 | 5 | 1.29 × 10-3 |
| PF00565 | Staphylococcal nuclease homolog | 5 | 3 | 4.03 × 10-3 |
| PF01416 | Pseudouridine synthesis | 4 | 3 | 1.75 × 10-3 |
| PF04719 | hTAFII28-like protein conserved region | 9 | 4 | 3.10 × 10-3 |
| PF01926 | 50S ribosome-binding GTPase | 2 | 2 | 6.08 × 10-3 |
| PF02270 | Transcription initiation factor IIF (TFIIF) | 22 | 7 | 8.81 × 10-4 |
| PF00226 | DnaJ domain | 4 | 3 | 1.75 × 10-3 |
| PF08423 | DNA repair and recombination | 19 | 6 | 2.12 × 10-3 |
| PF02450 | Lecithin:cholesterol acyltransferase | 2 | 2 | 6.08 × 10-3 |
| PF06728 | GPI transamidase subunit | 2 | 2 | 6.08 × 10-3 |
| PF01238 | Phosphomannose isomerase type I | 46 | 10 | 1.81 × 10-3 |
| PF00112 | Papain family cysteine protease | 6 | 3 | 7.44 × 10-3 |
| PF01067 | Calpain large subunit, domain III (protease) | 28 | 20 | 1.03 × 10-16 |
| PF00630 | Filamin/ABP280 repeat | 24 | 9 | 4.09 × 10-5 |
| PF01602 | Adaptin N-terminal region | 9 | 6 | 1.47 × 10-5 |
| PF04324 | BFD-like [2Fe-2S] binding domain | 4 | 3 | 1.75 × 10-3 |
| PF02777 | Iron/manganese superoxide dismutases, C-terminal domain | 8 | 4 | 1.87 × 10-3 |
| PF00400 | WD domain, G-beta repeat | 263 | 51 | 7.47 × 10-10 |
| PF13115 | YtkA-like: unknown function | 12 | 7 | 9.20 × 10-6 |
| PF06229 | FRG1-like family: unknown function | 4 | 3 | 1.75 × 10-3 |
| PF08238 | Sel1 repeat | 21 | 6 | 3.60 × 10-3 |
| PF00723 | Glycosyl hydrolases family 15 | 6 | 4 | 5.42 × 10-4 |
| PF00106 | Short chain dehydrogenase | 12 | 6 | 1.55 × 10-4 |
| PF01663 | Type I phosphodiesterase/nucleotide pyrophosphatase | 19 | 7 | 4.13 × 10-4 |
| PF02878 | Phosphoglucomutase/phosphomannomutase domain I | 3 | 3 | 5.29 × 10-4 |
| PF02880 | Phosphoglucomutase/phosphomannomutase domain III | 3 | 3 | 5.29 × 10-4 |
| PF00408 | Phosphoglucomutase/phosphomannomutase, C-terminal domain | 3 | 3 | 5.29 × 10-4 |
| PF00349 | Phosphorylates hexoses | 2 | 2 | 6.54 × 10-3 |
| PF01467 | Cytidylyltransferase | 9 | 6 | 1.82 × 10-5 |
| PF09334 | tRNA synthetases class I (M) | 3 | 3 | 5.29 × 10-4 |
| PF00432 | Prenyltransferase and squalene oxidase repeat | 4 | 4 | 4.27 × 10-5 |
| PF00630 | Filamin/ABP280 repeat | 28 | 25 | 1.10 × 10-24 |
| PF00307 | Calponin homology (CH) domain | 50 | 13 | 9.75 × 10-5 |
| PF06268 | Actin cross-linking | 6 | 5 | 1.90 × 10-5 |
| PF01602 | Adaptin N-terminal region | 24 | 9 | 5.41 × 10-5 |
| PF04324 | BFD-like [2Fe-2S] binding domain | 9 | 6 | 1.82 × 10-5 |
| PF00248 | Aldo/keto reductase family | 4 | 4 | 4.27 × 10-5 |
| PF02777 | Iron/manganese superoxide dismutases, C-terminal domain | 4 | 4 | 4.27 × 10-5 |
| PF00081 | Iron/manganese superoxide dismutases, alpha-hairpin domain | 5 | 4 | 1.96 × 10-4 |
| PF13115 | YtkA-like: unknown function | 12 | 8 | 6.40 × 10-7 |
| PF00501 | AMP-binding enzyme | 26 | 11 | 2.08 × 10-6 |
| PF12796 | Ankyrin repeats | 87 | 20 | 1.15 × 10-5 |
aSelected Pfam domains that were significantly enriched (P <0.05) in genes up- or down-regulated at 8 h, 24 h and 72 h post-encystation, and at 2 h post-excystation. bNumber of a Pfam domain in the whole E. invadens genome. cNumber of a Pfam domain among the subset of regulated genes. dP-value for Pfam domain enrichment.
Gene Ontology terms enriched in up- and down-regulated genes
| GO IDa | GO category name | Genes in genomeb | Genes in subsetc | |
|---|---|---|---|---|
| GO:0006030 | Chitin metabolism | 5 | 5 | 1.21 × 10-7 |
| GO:0006041 | Glucosamine metabolism | 5 | 5 | 1.21 × 10-7 |
| GO:0006807 | Nitrogen compound metabolism | 33 | 7 | 3.33 × 10-4 |
| GO:0009308 | Amine metabolism | 27 | 6 | 6.94 × 10-4 |
| GO:0005975 | Carbohydrate metabolism | 115 | 11 | 7.92 × 10-3 |
| GO:0001522 | Pseudouridine synthesis | 7 | 3 | 2.23 × 10-3 |
| GO:0007017 | Microtubule-based process | 13 | 4 | 1.57 × 10-3 |
| GO:0006030 | Chitin metabolism | 5 | 3 | 4.10 × 10-3 |
| GO:0006807 | Nitrogen compound metabolism | 33 | 7 | 1.15 × 10-2 |
| GO:0009308 | Amine metabolism | 27 | 6 | 1.52 × 10-2 |
| GO:0016311 | Dephosphorylation | 54 | 9 | 2.13 × 10-2 |
| GO:0006351 | Transcription, DNA-dependent | 35 | 6 | 4.96 × 10-2 |
| GO:0006367 | Transcription initiation from RNA polymerase II promoter | 11 | 3 | 4.78 × 10-2 |
| GO:0007017 | Microtubule-based process | 13 | 6 | 2.22 × 10-4 |
| GO:0007018 | Microtubule-based movement | 6 | 3 | 7.74 × 10-3 |
| GO:0009966 | Regulation of signal transduction | 120 | 13 | 7.62 × 10-3 |
| GO:0007275 | Development | 10 | 3 | 1.22 × 10-2 |
| GO:0040029 | Regulation of gene expression, epigenetic | 8 | 3 | 6.14 × 10-3 |
| GO:0006139 | Nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 328 | 24 | 4.39 × 10-2 |
| GO:0051056 | Regulation of small GTPase mediated | 120 | 13 | 7.62 × 10-3 |
| GO:0007017 | Microtubule-based process | 13 | 3 | 2.59 × 10-2 |
| GO:0019318 | Hexose metabolism | 21 | 8 | 9.38 × 10-4 |
| GO:0005975 | Carbohydrate metabolism | 115 | 23 | 2.00 × 10-3 |
| GO:0044262 | Cellular carbohydrate metabolism | 35 | 10 | 2.79 × 10-3 |
| GO:0006096 | Glycolysis | 7 | 4 | 3.51 × 10-3 |
| GO:0006007 | Glucose catabolism | 8 | 4 | 6.42 × 10-3 |
| GO:0006006 | Glucose metabolism | 17 | 6 | 6.47 × 10-3 |
| GO:0006066 | Alcohol metabolism | 28 | 8 | 7.31 × 10-3 |
| GO:0051186 | Cofactor metabolism | 54 | 12 | 1.02 × 10-2 |
| GO:0016052 | Carbohydrate catabolism | 10 | 4 | 1.62 × 10-2 |
| GO:0016226 | Iron-sulfur cluster assembly | 7 | 4 | 3.51 × 10-2 |
| GO:0042254 | Ribosome biogenesis and assembly | 18 | 5 | 3.65 × 10-2 |
| GO:0008654 | Phospholipid biosynthesis | 14 | 5 | 1.22 × 10-2 |
| GO:0046467 | Membrane lipid biosynthesis | 14 | 5 | 1.22 × 10-2 |
| GO:0006644 | Phospholipid metabolism | 25 | 7 | 1.34 × 10-2 |
| GO:0006497 | Protein lipidation | 10 | 4 | 1.62 × 10-2 |
| GO:0006508 | Proteolysis | 138 | 25 | 5.27 × 10-3 |
| GO:0006996 | Organelle organization and biogenesis | 112 | 21 | 6.85 × 10-3 |
| GO:0006800 | Oxygen and reactive oxygen species metabolism | 5 | 3 | 1.04 × 10-2 |
| GO:0006066 | Alcohol metabolism | 28 | 8 | 1.26 × 10-2 |
| GO:0005975 | Carbohydrate metabolism | 115 | 22 | 1.30 × 10-2 |
| GO:0019752 | Carboxylic acid metabolism | 26 | 8 | 7.82 × 10-3 |
| GO:0009059 | Macromolecule biosynthesis | 202 | 34 | 1.72 × 10-2 |
| GO:0006260 | DNA replication | 56 | 12 | 2.65 × 10-2 |
| GO:0006139 | Nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 328 | 50 | 2.69 × 10-2 |
| GO:0006259 | DNA metabolism | 144 | 25 | 2.71 × 10-2 |
| GO:0016568 | Chromatin modification | 11 | 4 | 3.17 × 10-2 |
| GO:0006629 | Lipid metabolism | 71 | 19 | 3.61 × 10-4 |
| GO:0008610 | Lipid biosynthesis | 21 | 7 | 7.88 × 10-3 |
| GO:0044255 | Cellular lipid metabolism | 38 | 10 | 1.02 × 10-2 |
| GO:0008654 | Phospholipid biosynthesis | 14 | 5 | 1.78 × 10-2 |
| GO:0006644 | Phospholipid metabolism | 25 | 7 | 2.15 × 10-2 |
| GO:0006497 | Protein lipidation | 10 | 4 | 2.22 × 10-2 |
| GO:0006508 | Proteolysis | 138 | 25 | 1.65 × 10-2 |
| GO:0006996 | Organelle organization and biogenesis | 112 | 21 | 1.87 × 10-2 |
| GO:0009309 | Amine biosynthesis | 10 | 3 | 1.38 × 10-3 |
| GO:0006519 | Amino acid and derivative metabolism | 23 | 4 | 1.86 × 10-3 |
| GO:0005975 | Carbohydrate metabolism | 115 | 8 | 5.37 × 10-3 |
| GO:0019752 | Carboxylic acid metabolism | 26 | 3 | 2.27 × 10-2 |
| GO:0051186 | Cofactor metabolism | 54 | 4 | 3.81 × 10-2 |
| GO:0016226 | Iron-sulfur cluster assembly | 7 | 4 | 9.80 × 10-6 |
| GO:0050896 | Response to stimulus | 46 | 4 | 3.14 × 10-2 |
| GO:0006323 | DNA packaging | 39 | 4 | 1.81 × 10-2 |
| GO:0051276 | Chromosome organization and biogenesis | 43 | 4 | 2.52 × 10-2 |
| GO:0006259 | DNA metabolism | 144 | 8 | 3.36 × 10-2 |
| GO:0046467 | Membrane lipid biosynthesis | 14 | 3 | 3.90 × 10-3 |
| GO:0006644 | Phospholipid metabolism | 25 | 3 | 2.04 × 10-2 |
| GO:0006497 | Protein lipidation | 10 | 3 | 1.38 × 10-3 |
| GO:0005975 | Carbohydrate metabolism | 115 | 7 | 2.99 × 10-2 |
| GO:0050896 | Response to stimulus | 46 | 4 | 3.14 × 10-2 |
| GO:0006323 | DNA packaging | 39 | 4 | 1.81 × 10-2 |
| GO:0051276 | Chromosome organization and biogenesis | 43 | 4 | 2.52 × 10-2 |
| GO:0006259 | DNA metabolism | 144 | 8 | 3.36 × 10-2 |
| GO:0031497 | Chromatin assembly | 30 | 3 | 4.27 × 10-2 |
| GO:0006461 | Protein complex assembly | 31 | 3 | 4.64 × 10-2 |
| GO:0006096 | Glycolysis | 7 | 5 | 2.22 × 10-4 |
| GO:0019320 | Hexose catabolism | 8 | 5 | 5.42 × 10-4 |
| GO:0046365 | Monosaccharide catabolism | 8 | 5 | 5.42 × 10-4 |
| GO:0006007 | Glucose catabolism | 8 | 5 | 5.42 × 10-4 |
| GO:0005996 | Monosaccharide metabolism | 22 | 8 | 1.19 × 10-3 |
| GO:0005975 | Carbohydrate metabolism | 115 | 23 | 1.58 × 10-3 |
| GO:0006092 | Main pathways of carbohydrate metabolism | 12 | 5 | 5.35 × 10-3 |
| GO:0016052 | Carbohydrate catabolism | 10 | 5 | 2.04 × 10-3 |
| GO:0016226 | Iron-sulfur cluster assembly | 7 | 4 | 3.28 × 10-3 |
| GO:0031163 | Metallo-sulfur cluster assembly | 7 | 4 | 3.28 × 10-3 |
| GO:0006629 | Lipid metabolism | 71 | 15 | 5.95 × 10-3 |
| GO:0051258 | Protein polymerization | 4 | 3 | 4.29 × 10-3 |
| GO:0030036 | Actin cytoskeleton organization and biogenesis | 7 | 4 | 3.28 × 10-3 |
| GO:0030041 | Actin filament polymerization | 4 | 3 | 4.29 × 10-3 |
| GO:0008154 | Actin polymerization and/or depolymerization | 4 | 3 | 4.29 × 10-3 |
| GO:0016043 | Cell organization and biogenesis | 306 | 51 | 3.70 × 10-4 |
| GO:0006996 | Organelle organization and biogenesis | 112 | 21 | 5.58 × 10-3 |
| GO:0006800 | Oxygen and reactive oxygen species metabolism | 5 | 4 | 5.58 × 10-4 |
| GO:0006801 | Superoxide metabolism | 5 | 4 | 5.58 × 10-4 |
| GO:0007154 | Cell communication | 566 | 23 | 3.73 × 10-2 |
| GO:0016043 | Cell organization and biogenesis | 306 | 14 | 4.47 × 10-2 |
| GO:0008643 | Carbohydrate transport | 5 | 3 | 3.56 × 10-3 |
| GO:0044249 | Cellular biosynthesis | 276 | 51 | 1.18 × 10-10 |
| GO:0006412 | Protein biosynthesis | 194 | 44 | 2.14 × 10-12 |
| GO:0006414 | Translational elongation | 11 | 3 | 4.21 × 10-2 |
| GO:0051276 | Chromosome organization and biogenesis | 43 | 9 | 3.42 × 10-3 |
| GO:0006323 | DNA packaging | 39 | 8 | 6.49 × 10-3 |
| GO:0031497 | Chromatin assembly | 30 | 6 | 2.01 × 10-2 |
| GO:0006334 | Nucleosome assembly | 23 | 6 | 5.27 × 10-3 |
| GO:0006461 | Protein complex assembly | 31 | 7 | 6.20 × 10-3 |
| GO:0016043 | Cell organization and biogenesis | 306 | 32 | 2.40 × 10-2 |
| GO:0006996 | Organelle organization and biogenesis | 112 | 14 | 3.41 × 10-2 |
aSelected GO terms that were significantly enriched (P < 0.05) in genes up- or down-regulated at 8 h, 24 h and 72 h post-encystation, and at 2 h post-excystation. bNumber of genes in a GO category in the whole E. invadens genome. cNumber of genes in a GO category among the subset of regulated genes. dP-value for GO category enrichment.
Figure 8Changes in expression levels of genes involved in meiosis. (a,b) Boxplots showing the distribution of expression values at each time point during encystation and excystation for meiosis-associated but not meiosis-specific genes (a) and for genes with meiosis-specific roles (b). There is a trend towards increased expression at 24 h after induction of encystation. This pattern of expression is consistent with a model in which meiotic division gives rise to the four nuclei in the cyst.
Figure 9Phospholipase D expression and function during encystation. The potential role of PLD in encystation was examined by observing the changes in expression and enzyme activity, and the effect of inhibition of PLD on encystation efficiency. (a) Expression of two E. invadens PLD genes. FPKM values for EIN_017100 and EIN_196230 at each encystation time point are shown. (b) PLD enzyme activity was measured using the Amplex Red Phospholipase D kit (Molecular Probes). Relative activity (measured as fluorescence at 585 nm and normalized to trophozoite activity) is shown for each time point. Error bars indicate ± standard deviation. (c) Inhibition of PLD decreases encystation efficiency. Encysting cultures of E. invadens were either untreated, treated with 0.6% n-butanol (an inhibitor of PLD activity) or with 0.6% t-butanol (which has no effect on PLD activity). Significant reduction of encystation efficiency (P < 0.01) was seen with n-butanol treatment, when compared to untreated parasites, but efficiency did not change with addition of t-butanol. Error bars indicate ± standard deviation. Insets show representative images of n-butanol and t-butanol treated samples, stained with calcofluor, which labels cysts. Note the higher percentage of positively staining cells in the t-butanol treated sample. (d) Inhibition of E. invadens PLD by n-butanol. To confirm that the effect of n-butanol on encystation was due to inhibition of PLD, enzyme activity of trophozoite lysate was measured in the presence of either n- or t-butanol. Relative activity (measured as fluorescence at 585 nm and normalized to activity in untreated lysate) is shown for each condition. Error bars indicate ± standard deviation.